Predictors of survival in human immunodeficiency virus-infected patients with pulmonary tuberculosis

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 6 I, 1996, Pages 1977-1981

  Whalen, C ^a   Okwera, A ^b   Johnson, J ^b   Vjecha, M ^b   Hom, D ^b   Wallis, R ^b   Huebner, R ^b   Mugerwa, R ^b   Ellner, J ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; THIOACETAZONE;

ADULT; ANEMIA; ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LEUKOPENIA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME; UGANDA;

EID: 0030014233     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.6.8665064     Document Type: Article

References (31)

1. Dolin, P. J., M. C. Raviglione, and A. Kochi. 1994. Global tuberculosis incidence and mortality during 1990-2000. Bull. W.H.O. 72:213-220.
2. Stoneburner, R., E. Laroche, R. Prevots, T. Singh, S. Blum, P. Terry, S. Reatrice, and J. Adler. 1992. Survival in a cohort of human immunodeficiency virus-infected tuberculosis patients in New York City. Arch. Intern. Med. 152:2033-2037.
3. Whalen, C., C. Lahart, D. Horn, M. Simberkoff, J. Ellner, and C. Horsburgh. 1995. Accelerated clinical course of HIV infection after tuberculosis. Am. J. Respir. Crit. Care Med. 151:129-135.
4. Small, P. M., G. F. Schecter, P. C. Goodman, M. A. Sande, R. E. Chaisson, and P. C. Hopewell. 1991. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 324:289-294.
5. Nunn, P., R. Brindle, L. Carpenter, J. Odhiambo, K. Wasunna, R. Newnham, W. Githui, S. Gathua, M. Omwega, and K. McAdam. 1992. Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya: analysis of early (six-month) mortality. Am. Rev. Respir. Dis. 146:849-854.
6. Fischl, M. A., G. L. Daikos, R. B. Uttamchandani, R. B. Poblete, J. N. Moreno, R. R. Reyes, A. M. Boota, L. M. Thompson, T. J. Cleary, S. A. Oldham, M. J. Saldana, and S. Lai. 1992. Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multi-drug-resistant bacilli. Ann. Intern. Med. 117:184-190.
7. Achak, A. N., D. Coulibaly, H. Digbeu, K. Diallo, K. Vetter, I. M. Coulibaly, A. E. Greenberg, and K. M. De Cock. 1995. Response to treatment, mortality, and CD4 lymphocyte count in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire. Lancet 345:607-610.
8. Wallis, R. S., M. S. Helfand, C. C. Whalen, J. J. Johnson, R. D. Mugerwa, M. Vjecha, A. Okwera, and J. J. Ellner. 1995. Association of macrophage activation with increased mortality in HIV-1 positive tuberculosis. Tubercle and Lung Disease (abstract). 76(Suppl. 2):132A.
9. Okwera, A., C. Whalen, F. Byekwaso, M. Vjecha, T. Aisu, C. Day-Lally, J. Nakibali, K. Edmonds, S. Nyole, R. Huebner, J. Johnson, D. Hom, R. Wallis, T. Daniel, R. Mugerwa, and J. Ellner. 1994. A randomized trial of thiacetazone- and rifampin-containing therapies for pulmonary tuberculosis in HIV-infection Ugandans. Lancet 334: 1323-1328.
10. Karnofsky, D. A., and J. H. Burchenal. 1949. The clinical evaluation of chemotherapeutic agents in cancer. In C. M. MacLeod, editor. Evaluation of Chemotherapeutic Agents. Columbia University Press, New York. 191-205.
11. Classification of Pulmonary Tuberculosis. 1969. Diagnostic Standards and Classification of Tuberculosis, chapter 6. National Tuberculosis and Respiratory Disease Association, New York.
12. International Union Against Tuberculosis and Lung Disease. 1986. Technical guide for sputum examination for tuberculosis by direct microscopy. Bull. IUATLD 61(Suppl. 2):1-6.
13. Harris, E. K., and A. Albert. 1991. Survivorship Analysis for Clinical Studies. Dekker, New York. 79-125.
14. Styblo, K. 1991. The impact of HIV infection on the global epidemiology of tuberculosis. Bull Union Tuberc. Lung Dis. 66:27-31.
15. Cantwell, M. F., D. E. Snider, G. M. Cauthen, and I. M. Onorato. 1994. Epidemiology of tuberculosis in the United States, 1985 through 1992. J.A.M.A. 272:535-539.
16. DeCock, K. M., B. Soro, I. M. Coulibaly, and S. B. Lucas. 1992. Tuberculosis and HIV infection in sub-Saharan Africa. J.A.M.A. 268:1581-1587.
17. Stephens, M. G. 1954. Pulmonary tuberculosis relapse and mortality. Am. Rev. Tuberc. 70:601-609.
18. Mitchell, R. S. 1955. Mortality and relapse of uncomplicated advanced pulmonary tuberculosis before chemotherapy: 1,504 consecutive admission followed for fifteen to twenty-five years. Am. Rev. Tuberc. 72:487-501.
19. Iseman, M. D. 1993. Treatment of multidrug-resistant tuberculosis. N. Engl. J., Med. 329:784-791.
20. Dannenburg, A. M. 1991. Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. Immunol. Today 12:228-233.
21. Fauci, A. S. 1988. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239:617-622.
22. Markowitz, N., N. I. Hansen, T. C. Wilcosky, P. C. Hopewell, J. Glassroth, P. A. Kvale, B. T. Mangura, D. Osmond, J. M. Wallace, M. J. Rosen, and L. B. Reichman. 1993. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Ann. Intern. Med. 119:185-193.
23. Mudaki, Y., J. H. Perriens, M. E. St. Louis, C. Brown, J. Prignot, J. C. Willame, F. Pouthier, M. Kaboto, R. W. Ryder, F. Portaels, and P. Piot. 1993. Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire. Lancet 342:143-146.
24. Jones, B. R., S. M. M. Young, D. Antoniskis, P. T. Davidson, F. Kramer, and P. F. Barnes. 1993. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am. Rev. Respir. Dis. 148:1292-1297.
25. Goodman, P. C. 1990. Pulmonary tuberculosis in patients with acquired immunodeficiency virus syndrome. J. Thorac. Imag. 5:38-45.
26. Alland, D., G. E. Kalkut, A. R. Moss, R. A. McAdam, J. A. Hahn, W. Bosworth, E. Drucker, and B. R. Bloom. 1994. Transmission of tuberculosis in New York City: An analysis by DNA fingerprinting and conventional epidemiologic methods. N. Engl. J. Med. 330: 1710-1716.
27. Small, P. M., P. C. Hopewell, S. P. Singh, A. Paz, J. Parsonnet, D. C. Ruston, G. F. Schecter, C. L. Daley, and G. K. Schoolnik. 1994. The epidemiology of tuberculosis in San Francisco: a population-based study using conventional and molecular methods. N. Engl. J. Med. 330:1703-1709.
28. The WHO International Collaborating Group for the Study of the WHO Staging System. 1993. Proposed 'World Health Organization Staging System for HIV Infection and Disease': preliminary testing by an international collaborative cross-sectional study. AIDS 7:711-718.
29. Wallis, R. S., M. Vjecha, M. Amir Tahmasseb, A. Okwera, F. Byekwaso, S. Nyole, S. Kabengera, R. Mugerwa, and J. Ellner. 1993. Influence of tuberculosis on human immunodeficiency virus (HIV-1): enhanced cytokine expression and elevated beta 2-microglobulin in HIV-1-associated tuberculosis. J. Infect. Dis. 167:43-48.
30. Takashima, T., C. Ueta, and S. Tsuyuguchi. 1990. Production of tumor necrosis factor alpha by monocytes from patients with pulmonary tuberculosis. Infect. Immunol. 58:3286-3292.
31. Kinter, A. L., G. Poli, W. Maury, T. M. Folks, and A. S. Fauci. 1990. Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells. J. Virol. 64:4306-4312.